RU2011134857A - Способы амплификации нуклеиновых кислот вируса гепатита с - Google Patents
Способы амплификации нуклеиновых кислот вируса гепатита с Download PDFInfo
- Publication number
- RU2011134857A RU2011134857A RU2011134857/10A RU2011134857A RU2011134857A RU 2011134857 A RU2011134857 A RU 2011134857A RU 2011134857/10 A RU2011134857/10 A RU 2011134857/10A RU 2011134857 A RU2011134857 A RU 2011134857A RU 2011134857 A RU2011134857 A RU 2011134857A
- Authority
- RU
- Russia
- Prior art keywords
- seq
- nucleotide sequence
- nucleotides
- primer
- independently
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract 57
- 241000711549 Hepacivirus C Species 0.000 title claims abstract 53
- 108020004707 nucleic acids Proteins 0.000 title claims abstract 26
- 102000039446 nucleic acids Human genes 0.000 title claims abstract 26
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract 26
- 230000003321 amplification Effects 0.000 title claims 10
- 238000003199 nucleic acid amplification method Methods 0.000 title claims 10
- 239000002773 nucleotide Substances 0.000 claims abstract 288
- 125000003729 nucleotide group Chemical group 0.000 claims abstract 288
- 238000003752 polymerase chain reaction Methods 0.000 claims abstract 64
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims abstract 15
- 102000040650 (ribonucleotides)n+m Human genes 0.000 claims abstract 8
- 230000000295 complement effect Effects 0.000 claims abstract 8
- 238000010839 reverse transcription Methods 0.000 claims 24
- 239000011541 reaction mixture Substances 0.000 claims 12
- 108020004414 DNA Proteins 0.000 claims 11
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims 8
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims 8
- 108010002747 Pfu DNA polymerase Proteins 0.000 claims 8
- 238000004458 analytical method Methods 0.000 claims 7
- 108091093088 Amplicon Proteins 0.000 claims 6
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 101800001554 RNA-directed RNA polymerase Proteins 0.000 claims 3
- 238000012163 sequencing technique Methods 0.000 claims 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims 2
- 101710118188 DNA-binding protein HU-alpha Proteins 0.000 claims 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims 2
- 101710144128 Non-structural protein 2 Proteins 0.000 claims 2
- 101710144111 Non-structural protein 3 Proteins 0.000 claims 2
- 101800001020 Non-structural protein 4A Proteins 0.000 claims 2
- 101800001019 Non-structural protein 4B Proteins 0.000 claims 2
- 101800001014 Non-structural protein 5A Proteins 0.000 claims 2
- 101710199667 Nuclear export protein Proteins 0.000 claims 2
- 230000001580 bacterial effect Effects 0.000 claims 2
- 229960003237 betaine Drugs 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 2
- SKTOEGXJUNJCDC-UHFFFAOYSA-N d(a20) s-oligo Chemical compound C1=NC2=C(N)N=CN=C2N1C(OC1COP(O)(=S)OC2C(OC(C2)N2C3=NC=NC(N)=C3N=C2)COP(O)(=S)OC2C(OC(C2)N2C3=NC=NC(N)=C3N=C2)COP(O)(=S)OC2C(OC(C2)N2C3=NC=NC(N)=C3N=C2)COP(O)(=S)OC2C(OC(C2)N2C3=NC=NC(N)=C3N=C2)COP(O)(=S)OC2C(OC(C2)N2C3=NC=NC(N)=C3N=C2)COP(O)(=S)OC2C(OC(C2)N2C3=NC=NC(N)=C3N=C2)COP(O)(=S)OC2C(OC(C2)N2C3=NC=NC(N)=C3N=C2)COP(O)(=S)OC2C(OC(C2)N2C3=NC=NC(N)=C3N=C2)COP(O)(=S)OC2C(OC(C2)N2C3=NC=NC(N)=C3N=C2)COP(O)(=S)OC2C(OC(C2)N2C3=NC=NC(N)=C3N=C2)COP(O)(=S)OC2C(OC(C2)N2C3=NC=NC(N)=C3N=C2)COP(O)(=S)OC2C(OC(C2)N2C3=NC=NC(N)=C3N=C2)COP(O)(=S)OC2C(OC(C2)N2C3=NC=NC(N)=C3N=C2)COP(O)(=S)OC2C(OC(C2)N2C3=NC=NC(N)=C3N=C2)COP(O)(=S)OC2C(OC(C2)N2C3=NC=NC(N)=C3N=C2)COP(O)(=S)OC2C(OC(C2)N2C3=NC=NC(N)=C3N=C2)COP(O)(=S)OC2C(OC(C2)N2C3=NC=NC(N)=C3N=C2)COP(O)(=S)OC2C(OC(C2)N2C3=NC=NC(N)=C3N=C2)CO)CC1OP(O)(=S)OCC(O1)C(O)CC1N1C(N=CN=C2N)=C2N=C1 SKTOEGXJUNJCDC-UHFFFAOYSA-N 0.000 claims 2
- 238000011534 incubation Methods 0.000 claims 2
- 239000011159 matrix material Substances 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108020005345 3' Untranslated Regions Proteins 0.000 claims 1
- 108020003589 5' Untranslated Regions Proteins 0.000 claims 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 claims 1
- 108091036066 Three prime untranslated region Proteins 0.000 claims 1
- 238000010367 cloning Methods 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
- C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2531/00—Reactions of nucleic acids characterised by
- C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
- C12Q2531/113—PCR
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Pathology (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14608309P | 2009-01-21 | 2009-01-21 | |
| US61/146,083 | 2009-01-21 | ||
| PCT/US2010/021589 WO2010090857A2 (en) | 2009-01-21 | 2010-01-21 | Methods for amplifying hepatitis c virus nucleic acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2011134857A true RU2011134857A (ru) | 2013-02-27 |
Family
ID=42334055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2011134857/10A RU2011134857A (ru) | 2009-01-21 | 2010-01-21 | Способы амплификации нуклеиновых кислот вируса гепатита с |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US8679740B2 (enExample) |
| EP (1) | EP2389452A2 (enExample) |
| JP (1) | JP2012515534A (enExample) |
| KR (1) | KR20120101278A (enExample) |
| CN (1) | CN102341506A (enExample) |
| AU (1) | AU2010210892A1 (enExample) |
| CA (1) | CA2749969A1 (enExample) |
| IL (1) | IL214195A0 (enExample) |
| MX (1) | MX2011007693A (enExample) |
| NZ (1) | NZ594155A (enExample) |
| RU (1) | RU2011134857A (enExample) |
| WO (1) | WO2010090857A2 (enExample) |
| ZA (1) | ZA201105349B (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX352987B (es) | 2007-10-02 | 2017-12-15 | Theranos Ip Co Llc | Dispositivos modulares de punto de cuidado y usos de los mismos. |
| CA2825196C (en) | 2011-01-21 | 2021-01-05 | Theranos, Inc. | Systems and methods for sample use maximization |
| US9619627B2 (en) | 2011-09-25 | 2017-04-11 | Theranos, Inc. | Systems and methods for collecting and transmitting assay results |
| US9632102B2 (en) | 2011-09-25 | 2017-04-25 | Theranos, Inc. | Systems and methods for multi-purpose analysis |
| US8475739B2 (en) | 2011-09-25 | 2013-07-02 | Theranos, Inc. | Systems and methods for fluid handling |
| US20140170735A1 (en) | 2011-09-25 | 2014-06-19 | Elizabeth A. Holmes | Systems and methods for multi-analysis |
| US9268915B2 (en) | 2011-09-25 | 2016-02-23 | Theranos, Inc. | Systems and methods for diagnosis or treatment |
| US8840838B2 (en) | 2011-09-25 | 2014-09-23 | Theranos, Inc. | Centrifuge configurations |
| US9664702B2 (en) | 2011-09-25 | 2017-05-30 | Theranos, Inc. | Fluid handling apparatus and configurations |
| US9250229B2 (en) | 2011-09-25 | 2016-02-02 | Theranos, Inc. | Systems and methods for multi-analysis |
| US10012664B2 (en) | 2011-09-25 | 2018-07-03 | Theranos Ip Company, Llc | Systems and methods for fluid and component handling |
| US9810704B2 (en) | 2013-02-18 | 2017-11-07 | Theranos, Inc. | Systems and methods for multi-analysis |
| CN105683751B (zh) | 2013-09-06 | 2020-01-17 | 赛拉诺斯知识产权有限责任公司 | 用于接收拭子的装置、系统、方法和套件 |
| BR112016004994A2 (pt) | 2013-09-06 | 2021-05-11 | Theranos Ip Company, Llc | Sistemas e métodos para detectar doenças infecciosas |
| CN106222306A (zh) * | 2016-08-30 | 2016-12-14 | 合肥金域医学检验所有限公司 | 一种hcv病毒ns5a蛋白编码序列突变检测试剂盒 |
| GB201819726D0 (en) * | 2018-12-03 | 2019-01-16 | Diagnostics For The Real World Ltd | HCV detection |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
| US4415732A (en) | 1981-03-27 | 1983-11-15 | University Patents, Inc. | Phosphoramidite compounds and processes |
| US4973679A (en) | 1981-03-27 | 1990-11-27 | University Patents, Inc. | Process for oligonucleo tide synthesis using phosphormidite intermediates |
| DE3329892A1 (de) | 1983-08-18 | 1985-03-07 | Köster, Hubert, Prof. Dr., 2000 Hamburg | Verfahren zur herstellung von oligonucleotiden |
| FR2596761B1 (fr) | 1986-04-08 | 1988-05-20 | Commissariat Energie Atomique | Derives de nucleosides et leur utilisation pour la synthese d'oligonucleotides |
| US5322770A (en) | 1989-12-22 | 1994-06-21 | Hoffman-Laroche Inc. | Reverse transcription with thermostable DNA polymerases - high temperature reverse transcription |
| US5310652A (en) | 1986-08-22 | 1994-05-10 | Hoffman-La Roche Inc. | Reverse transcription with thermostable DNA polymerase-high temperature reverse transcription |
| EP0787807B1 (en) | 1991-08-27 | 2003-05-28 | F. Hoffmann-La Roche Ag | Primers and probes for hepatitis C detection |
| EP0532258A2 (en) * | 1991-09-09 | 1993-03-17 | Immuno Japan Inc. | Oligonucleotides and determination system of HCV genotypes |
| JPH0775585A (ja) * | 1993-06-14 | 1995-03-20 | Immuno Japan:Kk | Ｃ型肝炎ウイルス関連オリゴヌクレオチドならびにｃ型肝炎 ウイルス遺伝子型判定方法 |
| ZA966663B (en) | 1995-08-17 | 1998-02-06 | Genentech Inc | Traf Inhibitors. |
| US6153421A (en) * | 1997-07-18 | 2000-11-28 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Cloned genomes of infectious hepatitis C viruses and uses thereof |
| WO2002064842A2 (en) * | 2001-02-13 | 2002-08-22 | Children`S Hospital Research Foundation | Quantitative epstein barr virus pcr rapid assay |
| JP3751867B2 (ja) * | 2001-09-18 | 2006-03-01 | 株式会社東芝 | インターフェロンを投与されるべき個体においてインターフェロン療法の有効性を予測する方法、その方法をコンピュータにより実行させるためのプログラム、インターフェロン感受性に関連する多型部位の遺伝子型を検出するための核酸プローブ、およびその核酸プローブを具備する塩基配列検出用チップ |
| AU2003230790A1 (en) * | 2002-04-03 | 2003-10-20 | Smithkline Beecham Corporation | Hepatitis c virus sub-genomic replicons |
| US20040137539A1 (en) * | 2003-01-10 | 2004-07-15 | Bradford Sherry A. | Cancer comprehensive method for identifying cancer protein patterns and determination of cancer treatment strategies |
| WO2004073599A2 (en) | 2003-02-18 | 2004-09-02 | Pfizer Inc. | Inhibitors of hepatitis c virus, compositions and treatments using the same |
| US20050282179A1 (en) | 2003-12-05 | 2005-12-22 | Applera Corporation | Biomarkers for interferon-alpha response in hepatitis C virus infected patients |
| JPWO2006085407A1 (ja) * | 2005-02-09 | 2008-12-18 | 学校法人日本大学 | Ｈｃｖ量に関連する遺伝子のスクリーニング方法 |
| EP2711427A1 (en) * | 2007-04-27 | 2014-03-26 | Advanced Life Science Institute, Inc. | HCV gene |
| JP4213759B2 (ja) * | 2007-08-10 | 2009-01-21 | 株式会社東芝 | 標的核酸の遺伝子型、および変異の判定方法、不溶性支持体に核酸断片を固定化する方法、所望の核酸を精製し、かつ増幅するための方法、並びに遺伝子型アッセイキット |
-
2010
- 2010-01-21 AU AU2010210892A patent/AU2010210892A1/en not_active Abandoned
- 2010-01-21 CN CN2010800098527A patent/CN102341506A/zh active Pending
- 2010-01-21 NZ NZ594155A patent/NZ594155A/xx not_active IP Right Cessation
- 2010-01-21 CA CA2749969A patent/CA2749969A1/en not_active Abandoned
- 2010-01-21 JP JP2011546450A patent/JP2012515534A/ja active Pending
- 2010-01-21 WO PCT/US2010/021589 patent/WO2010090857A2/en not_active Ceased
- 2010-01-21 KR KR1020117019326A patent/KR20120101278A/ko not_active Withdrawn
- 2010-01-21 MX MX2011007693A patent/MX2011007693A/es not_active Application Discontinuation
- 2010-01-21 EP EP10703544A patent/EP2389452A2/en not_active Ceased
- 2010-01-21 RU RU2011134857/10A patent/RU2011134857A/ru not_active Application Discontinuation
-
2011
- 2011-07-19 IL IL214195A patent/IL214195A0/en unknown
- 2011-07-20 ZA ZA2011/05349A patent/ZA201105349B/en unknown
- 2011-07-20 US US13/186,985 patent/US8679740B2/en not_active Expired - Fee Related
-
2014
- 2014-01-28 US US14/165,757 patent/US20140199684A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN102341506A (zh) | 2012-02-01 |
| WO2010090857A2 (en) | 2010-08-12 |
| KR20120101278A (ko) | 2012-09-13 |
| WO2010090857A8 (en) | 2012-06-28 |
| AU2010210892A1 (en) | 2011-08-11 |
| NZ594155A (en) | 2013-02-22 |
| CA2749969A1 (en) | 2010-08-12 |
| US8679740B2 (en) | 2014-03-25 |
| US20140199684A1 (en) | 2014-07-17 |
| WO2010090857A3 (en) | 2010-11-25 |
| IL214195A0 (en) | 2011-08-31 |
| MX2011007693A (es) | 2011-09-27 |
| US20120129155A1 (en) | 2012-05-24 |
| EP2389452A2 (en) | 2011-11-30 |
| ZA201105349B (en) | 2013-10-30 |
| JP2012515534A (ja) | 2012-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2011134857A (ru) | Способы амплификации нуклеиновых кислот вируса гепатита с | |
| JP2012515534A5 (enExample) | ||
| Kolykhalov et al. | Identification of a highly conserved sequence element at the 3'terminus of hepatitis C virus genome RNA | |
| CN108330210B (zh) | 寨卡病毒、登革热病毒和基孔肯雅病毒核酸检测试剂盒及其用途 | |
| AU2009301125B2 (en) | Method for determining drug resistance mutations in any of the non-structural protein regions NS3 to NS5B of Hepatitis C Virus (HCV) for genotypes 1 to 6 | |
| Fahnøe et al. | Full-length open reading frame amplification of hepatitis C virus | |
| US20110136678A1 (en) | Methodology for analysis of sequence variations within the hcv ns3/4a genomic region | |
| CN116134157A (zh) | 用于扩增和检测sars-cov-2的基于pcr的诊断试剂盒、组合物和方法 | |
| CN108467904B (zh) | 检测塞尼卡谷病毒的rt-lamp引物组、试剂盒及应用 | |
| CN113215327A (zh) | 一种检测gⅱ型诺如病毒的引物探针组、试剂盒及方法 | |
| Anwar et al. | A stem–loop-mediated reverse transcription real-time PCR for the selective detection and quantification of the replicative strand of an RNA virus | |
| CN113862396B (zh) | 一种鹅Pegivirus环介导等温扩增检测引物组及试剂盒 | |
| Papin et al. | Genome-wide real-time PCR for West Nile virus reduces the false-negative rate and facilitates new strain discovery | |
| US20160177407A1 (en) | Method for determining drug resistance mutations in any of the non-structural protein regions ns3 to ns5b of hepatitis c virus (hcv) for genotypes 1 to 6 | |
| CN116411139A (zh) | 用于多亚型hiv-1检测的通用型引物组、探针及检测方法 | |
| CN103060472A (zh) | 一种丙型肝炎病毒环介导等温扩增检测试剂盒 | |
| AU2003259017A1 (en) | Strand specific detection and quantification | |
| Athar et al. | Microbiological & Immunological Communications | |
| Niedbalski et al. | Detection of SVDV RNA amplified by the polymerase chain reaction (PCR) | |
| CN120006030A (zh) | 基于双重信号放大技术现场快速检测鱼类弹状病毒caprv2023的引物及其应用 | |
| Xu et al. | Real-time quantitative assay of HCV RNA using the duplex scorpion primer | |
| Vythilingam et al. | Nucleotide and amino acid sequences in the preM region of a Japanese encephalitis virus strain isolated from a pool of Aedes albopictus and Ae. butleri mosquitoes captured in Peninsula Malaysia in 1992 | |
| CN116814860A (zh) | 一种检测黄热病毒的引物探针组合和试剂盒 | |
| Athar et al. | Molecular Diagnosis of Hepatitis C Viruses; Technologies and Its Clinical Applications | |
| HK1163188A (en) | Methods for amplifying hepatitis c virus nucleic acids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20141008 |